Postoperative Clostridium difficile-associated diarrhea

Surgery

Volumn 148, Issue 1, 2010, Pages 24-30

  Southern, William N ^a   Rahmani, Rabin ^a   Aroniadis, Olga ^a   Khorshidi, Igal ^a   Thanjan, Andy ^a   Ibrahim, Christopher ^a   Brandt, Lawrence J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR; SERUM ALBUMIN;

ABDOMINAL SURGERY; ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SURGICAL RISK; TREATMENT OUTCOME;

ABDOMEN; ADULT; AGED; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 77953289077     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.11.021     Document Type: Article

References (40)

1. Gerding D.N. Disease associated with Clostridium difficile infection. Ann Intern Med 110 (1989) 255-257
2. Archibald L.K., Banerjee S.N., and Jarvis W.R. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 189 (2004) 1585-1589
3. Redelings M.D., Sorvillo F., and Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13 (2007) 1417-1419
4. Hermsen J.L., Dobrescu C., and Kudsk K.A. Clostridium difficile infection: a surgical disease in evolution. J Gastrointest Surg 12 (2008) 1512-1517
5. Ricciardi R., Rothenberger D.A., Madoff R.D., and Baxter N.N. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142 (2007) 624-631
6. Zilberberg M.D., Shorr A.F., and Kollef M.H. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 14 (2008) 929-931
7. Kent K.C., Rubin M.S., Wroblewski L., Hanff P.A., and Silen W. The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg 227 (1998) 296-301
8. Harbarth S., Samore M.H., and Carmeli Y. Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J Hosp Infect 48 (2001) 93-97
9. Wren S.M., Ahmed N., Jamal A., and Safadi B.Y. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg 140 (2005) 752-756
10. McCarter M.D., Abularrage C., Velasco F.T., Davis J.M., and Daly J.M. Diarrhea and Clostridium difficile-associated diarrhea on a surgical service. Arch Surg 131 (1996) 1333-1337
11. Bulstrode N.W., Bradbury A.W., Barrett S., Stansby G., Mansfield A.O., Nicolaides A.N., et al. Clostridium difficile colitis after aortic surgery. Eur J Vasc Endovasc Surg 14 (1997) 217-220
12. Crabtree T., Aitchison D., Meyers B.F., Tymkew H., Smith J.R., Guthrie T.J., et al. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg 83 (2007) 1396-1402
13. Geroulanos S., Donfried B., Schumacher F., and Turina M. Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery. Drugs Exp Clin Res 11 (1985) 201-205
14. Aronsson B., Mollby R., and Nord C.E. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 151 (1985) 476-481
15. Wistrom J., Norrby S.R., Myhre E.B., Eriksson S., Granström G., Lagergren L., et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47 (2001) 43-50
16. Karlstrom O., Fryklund B., Tullus K., and Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 26 (1998) 141-145
17. Pepin J., Valiquette L., and Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173 (2005) 1037-1042
18. Marra A.R., Edmond M.B., Wenzel R.P., and Bearman G.M. Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis 7 (2007) 42
19. Kyne L., Sougioultzis S., McFarland L.V., and Kelly C.P. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23 (2002) 653-659
20. Dial S., Delaney J.A., Barkun A.N., and Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
21. Dial S., Delaney J.A., Schneider V., and Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 175 (2006) 745-748
22. Aseeri M., Schroeder T., Kramer J., and Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (2008) 2308-2313
23. Price M.F., Dao-Tran T., Garey K.W., Graham G., Gentry L.O., Dhungana L., et al. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 65 (2007) 42-46
24. Bliss D.Z., Johnson S., Savik K., Clabots C.R., Willard K., and Gerding D.N. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 129 (1998) 1012-1019
25. Kamthan A.G., Bruckner H.W., Hirschman S.Z., and Agus S.G. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med 152 (1992) 1715-1717
26. Dubberke E.R., Butler A.M., Reske K.A., Agniel D., Olsen M.A., D'Angelo G., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 14 (2008) 1031-1038
27. Issa M., Vijayapal A., Graham M.B., Beaulieu D.B., Otterson M.F., Lundeen S., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 345-351
28. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
29. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
30. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
31. D'Agostino Jr. R.B., and D'Agostino Sr. R.B. Estimating treatment effects using observational data. JAMA 297 (2007) 314-316
32. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching. [computer program] (2003), Boston College School of Economics
33. Clarke J.S., Condon R.E., Bartlett J.G., Gorbach S.L., Nichols R.L., and Ochi S. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 186 (1977) 251-259
34. Lewis R.T. Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg 45 (2002) 173-180
35. Martin L.F. Stress ulcers are common after aortic surgery. Endoscopic evaluation of prophylactic therapy. Am Surg 60 (1994) 169-174
36. Spirt M.J. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 26 (2004) 197-213
37. Kyne L., Warny M., Qamar A., and Kelly C.P. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357 9251 (2001) 189-193
38. Svenungsson B., Burman L.G., Jalakas-Pörnull K., Lagergren A., Struwe J., and Akerlund T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol 41 (2003) 4031-4037
39. West M., Pirenne J., Chavers B., Gillingham K., Sutherland D.E., Dunn D.L., et al. Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplant 13 (1999) 318-323
40. Hammer J.H., Nielsen H.J., Moesgaard F., and Kehlet H. Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res 24 (1992) 133-137